Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 45 | 51 | +6 |
| Shares | 8.95M | 8.88M | −67.7K (−0.8%) |
| Value | $82.0M | $72.1M | −$9.93M (−12.1%) |
New holders (10)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 29,640 | $240.0K | 0.00% |
| Bridgeway Capital Management, LLC | 24,550 | $199.0K | 0.00% |
| Truist Financial Corp | 11,298 | $92.0K | 0.00% |
| Goldman Sachs Group Inc | 10,802 | $88.0K | 0.00% |
| Amalgamated Bank | 2,133 | $17.0K | 0.00% |
| Amalgamated Financial Corp. | 2,133 | $17.0K | 0.00% |
| Asset Dedication, LLC | 1,193 | $10.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 427 | $3.00K | 0.00% |
| CWM, LLC | 55 | $0 | 0.00% |
| Ellevest, Inc. | 14 | $0 | 0.00% |
Sold out (4)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| PDT Partners, LLC | 10,800 | $99.0K |
| Nisa Investment Advisors, LLC | 3,100 | $25.0K |
| CoreCap Advisors, LLC | 200 | $2.00K |
| Massmutual Trust Co FSB | 65 | $1.00K |